ImportantUpdates
Sat Kartar Life plans a ~₹48.59 Cr fundraise through preferential issue of equity shares and convertible warrants to boost its integrated healthcare platform.
Sat Kartar Shopping LimitedSATKARTAR · Filed with the exchange
Separately, it will acquire the remaining 24% of Plantomed Neutraceuticals for ₹1.21 Cr, making it a wholly-owned subsidiary for product and brand growth.
No comments yet. Be the first.